-+ 0.00%
-+ 0.00%
-+ 0.00%

PLUS THERAPEUTICS RECEIVES AMA PLA CODE FOR CNSIDE® CSF TUMOR CELL ENUMERATION TEST, ADVANCING REIMBURSEMENT AND U.S. COMMERCIAL ADOPTION

Reuters·04/07/2026 11:31:04

Please log in to view news